Vir Biotechnology (VIR) FCF Margin (QoQ) (2019 - 2026)
Vir Biotechnology (VIR) FCF Margin (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Vir Biotechnology | 1.38 Bn | 1.38 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -45.78 Mn |
| Dec 31, 2025 | 6.99 Mn |
| Sep 30, 2025 | -5.98 Mn |
| Jun 30, 2025 | -748,167.00 |
| Mar 31, 2025 | -190,577.00 |
| Dec 31, 2024 | 659,700.00 |
| Sep 30, 2024 | -476,808.00 |
| Jun 30, 2024 | -233,806.00 |
| Mar 31, 2024 | 43,686.00 |
| Dec 31, 2023 | 539,352.00 |
| Sep 30, 2023 | 445,491.00 |
| Jun 30, 2023 | -1.03 Mn |
| Mar 31, 2023 | -25,634.00 |
| Dec 31, 2022 | 1,924.00 |
| Sep 30, 2022 | -228,607.00 |
| Jun 30, 2022 | 226,913.00 |
| Mar 31, 2022 | 4,457.00 |
| Dec 31, 2021 | 10,254.00 |
| Sep 30, 2021 | -18,573.00 |
| Jun 30, 2021 | 463,192.00 |